Pfizer (PFE) stock may present opportunities for patient investors. Read how this biotech giant may deliver long-term ...

Some misleading narratives about Bourla’s leadership that have been put forward have been distinctly unfair,' write Jeff ...

Pfizer (PFE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Every investor in Pfizer Inc. ( NYSE:PFE) should be aware of the most powerful shareholder groups. We can see that ...

(NYSE: PFE) today announced positive topline results from the final prespecified overall survival (OS) analysis of the ...

Shares of Pfizer (NYSE: PFE) have been stuck in the mud since December 2022, with its shares down more than 45% over that ...

ETFs such as The Schwab US Dividend ETF can be useful, but a 'DIY' approach can help you outperform. Here are 3 of the best ...

Pfizer ($PFE) has long been a staple in the portfolios of income-oriented investors, especially those drawn to its consistent ...

Once a top-performing stock thanks to its role in developing the first Covid-19 vaccine, Pfizer has seen its share price drop by nearly half from its 2021 peak.

The FDA recently approved the updated mRNA Pfizer and Moderna boosters, as well as the updated Novavax COVID vaccine, to ...

PepsiCo ( PEP 0.03%) and Costco ( COST 0.10%) offer stability in the consumer staples sector. PepsiCo stock yields 3.19% with ...

Pfizer shares are on the up since US activist investor Starboard Value built up a stake in the drug maker. But strategic ...